Advances and critical concerns with the microfluidic enrichments of circulating tumor cells.

Over the past two decades, circulating tumor cells (CTCs) have been widely recognized for their importance in clinical trials. While most enrichment methods for these cells have been conducted through the batch process due to their rarity in blood and the need for large sample volumes, the batch process leads to unavoidable cell loss. Given the heterogenetic features of CTCs, this cell loss may limit the validity of research that relies on the isolation of CTCs; such research includes cancer prognosis, diagnosis of minimal residual diseases, assessment of tumor sensitivity to anticancer drugs, and the personalization of anticancer therapies. Recent advances in microfluidic approaches have made it possible to enrich CTCs with a small degree of cell loss. In this review, we highlight several microfluidic-based positive and negative enrichment methods that are the subject of considerable research interest (e.g. EpCAM-dependent assay and EpCAM-independent assay) and suggest a microfluidic-based single cell analysis platform for the down-stream analysis of CTCs. We also discuss critical concerns and future directions for research.

[1]  Kyung-A Hyun,et al.  Microfluidic devices for the isolation of circulating rare cells: A focus on affinity‐based, dielectrophoresis, and hydrophoresis , 2013, Electrophoresis.

[2]  Yi-Kuen Lee,et al.  Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers. , 2011, Angewandte Chemie.

[3]  M. Peters,et al.  Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines , 2005, British Journal of Cancer.

[4]  Gyan Bhanot,et al.  Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines , 2012, PloS one.

[5]  J. Rao,et al.  Nanomechanical analysis of cells from cancer patients. , 2007, Nature nanotechnology.

[6]  John A. Foekens,et al.  Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR , 2009, Breast Cancer Research and Treatment.

[7]  Peter C. Y. Chen,et al.  Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells. , 2014, Lab on a chip.

[8]  Kazunori Hoshino,et al.  Immunomagnetic nanoscreening of circulating tumor cells with a motion controlled microfluidic system , 2012, Biomedical Microdevices.

[9]  Mingzhou Guo,et al.  Spatially gradated segregation and recovery of circulating tumor cells from peripheral blood of cancer patients. , 2013, Biomicrofluidics.

[10]  Robert H. Austin,et al.  Continuous microfluidic immunomagnetic cell separation , 2004 .

[11]  H. Lilja,et al.  Microfluidic, label-free enrichment of prostate cancer cells in blood based on acoustophoresis. , 2012, Analytical chemistry.

[12]  T. Fehm,et al.  Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials , 2012, Cancer and Metastasis Reviews.

[13]  Sridhar Ramaswamy,et al.  Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.

[14]  Tomoko Yoshino,et al.  Size-selective microcavity array for rapid and efficient detection of circulating tumor cells. , 2010, Analytical chemistry.

[15]  F. Bischoff,et al.  FISH-based determination of HER2 status in circulating tumor cells isolated with the microfluidic CEE™ platform. , 2011, Cancer genetics.

[16]  Kyung-A Hyun,et al.  Negative enrichment of circulating tumor cells using a geometrically activated surface interaction chip. , 2013, Analytical chemistry.

[17]  Swee Jin Tan,et al.  Microdevice for the isolation and enumeration of cancer cells from blood , 2009, Biomedical microdevices.

[18]  Kazuo Takeda,et al.  Enumeration, characterization, and collection of intact circulating tumor cells by cross contamination‐free flow cytometry , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[19]  Minseok S Kim,et al.  Highly efficient assay of circulating tumor cells by selective sedimentation with a density gradient medium and microfiltration from whole blood. , 2012, Analytical chemistry.

[20]  Chang-Yu Chen,et al.  Separation and detection of rare cells in a microfluidic disk via negative selection. , 2011, Lab on a chip.

[21]  I. Tinhofer,et al.  Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition , 2012, BMC Cancer.

[22]  Hakho Lee,et al.  Microfluidic Cell Sorter (μFCS) for On‐chip Capture and Analysis of Single Cells , 2012, Advanced healthcare materials.

[23]  H. Jung,et al.  Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP). , 2011, Lab on a chip.

[24]  Hongtao Feng,et al.  High throughput capture of circulating tumor cells using an integrated microfluidic system. , 2013, Biosensors & bioelectronics.

[25]  B. Greene,et al.  Microtube device for selectin-mediated capture of viable circulating tumor cells from blood. , 2012, Clinical chemistry.

[26]  Polymer nanofiber-embedded microchips for detection, isolation, and molecular analysis of single circulating melanoma cells. , 2013, Angewandte Chemie.

[27]  D. Burgess Breast cancer: Circulating and dynamic EMT , 2013, Nature Reviews Cancer.

[28]  Klaus Pantel,et al.  Circulating tumour cells in cancer patients: challenges and perspectives. , 2010, Trends in molecular medicine.

[29]  G. Whitesides The origins and the future of microfluidics , 2006, Nature.

[30]  Bo Lu,et al.  3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood , 2011, Biomedical microdevices.

[31]  C. Punt,et al.  Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[32]  Caroline Dive,et al.  Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  C. Y. Teo,et al.  Cell loss in integrated microfluidic device , 2007, Biomedical microdevices.

[34]  Jason G. Kralj,et al.  Engineering and analysis of surface interactions in a microfluidic herringbone micromixer. , 2012, Lab on a chip.

[35]  Donald E Ingber,et al.  A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells. , 2012, Lab on a chip.

[36]  A. Puisieux,et al.  Metastasis: a question of life or death , 2006, Nature Reviews Cancer.

[37]  R. Hynes,et al.  Determination of 35 cell surface antigen levels in malignant pleural effusions identifies CD24 as a marker of disseminated tumor cells , 2013, International journal of cancer.

[38]  Ram Datar,et al.  Circulating tumor cells: from bench to bedside. , 2013, Annual review of medicine.

[39]  Wei Liu,et al.  CORRIGENDUM: Biodegradation-inspired bioproduction of methylacetoin and 2-methyl-2,3-butanediol , 2013, Scientific Reports.

[40]  Inhak Choi,et al.  Circulating tumor cell microseparator based on lateral magnetophoresis and immunomagnetic nanobeads. , 2013, Analytical chemistry.

[41]  Kyung-A Hyun,et al.  Continual collection and re-separation of circulating tumor cells from blood using multi-stage multi-orifice flow fractionation. , 2013, Biomicrofluidics.

[42]  H. Jung,et al.  Continuous labeling of circulating tumor cells with microbeads using a vortex micromixer for highly selective isolation. , 2013, Biosensors & bioelectronics.

[43]  K. Isselbacher,et al.  Isolation of circulating tumor cells using a microvortex-generating herringbone-chip , 2010, Proceedings of the National Academy of Sciences.

[44]  Tobias M. Gorges,et al.  Circulating tumor cells as therapy-related biomarkers in cancer patients , 2013, Cancer Immunology, Immunotherapy.

[45]  Jeong-Gun Lee,et al.  SSA-MOA: a novel CTC isolation platform using selective size amplification (SSA) and a multi-obstacle architecture (MOA) filter. , 2012, Lab on a chip.

[46]  김승일 A Trachea-Inspired Bifurcated Microfilter Capturing Viable Circulating Tumor Cells via Altered Biophysical Properties as Measured by Atomic Force Microscopy , 2013 .

[47]  Richard Novak,et al.  High-performance single cell genetic analysis using microfluidic emulsion generator arrays. , 2010, Analytical chemistry.

[48]  Chao Liu,et al.  Double spiral microchannel for label-free tumor cell separation and enrichment. , 2012, Lab on a chip.

[49]  Gwo-Bin Lee,et al.  High-purity and label-free isolation of circulating tumor cells (CTCs) in a microfluidic platform by using optically-induced-dielectrophoretic (ODEP) force. , 2013, Lab on a chip.

[50]  Chiun-Sheng Huang,et al.  Enumeration and viability of rare cells in a microfluidic disk via positive selection approach. , 2012, Analytical biochemistry.

[51]  Kyung-A Hyun,et al.  Microfluidic flow fractionation device for label-free isolation of circulating tumor cells (CTCs) from breast cancer patients. , 2013, Biosensors & bioelectronics.

[52]  Sudhir Srivastava,et al.  A simple packed bed device for antibody labelled rare cell capture from whole blood. , 2012, Lab on a chip.

[53]  Minseok S Kim,et al.  A trachea-inspired bifurcated microfilter capturing viable circulating tumor cells via altered biophysical properties as measured by atomic force microscopy. , 2013, Small.